Navigation Links
Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/7/2009

SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced its financial results for the first quarter ended March 31, 2009. Optimer reported a net loss for the first quarter of 2009 of $10.9 million, or $0.36 per share which was in line with the Company's expectations. This compares to a net loss for the first quarter of 2008 of $7.9 million, or $0.28 per share. Research and development expenses in the first quarter of 2009 were $8.8 million compared to $6.9 million in the first quarter of 2008. The increase is primarily due to an increase in clinical development and regulatory expenses related to Optimer's fidaxomicin and prulifloxacin programs.

As of March 31, 2009, Optimer held cash, cash equivalents and short-term investments of $62.6 million.

"We are off to a strong start in 2009," said Michael N. Chang, Ph.D., Optimer's President and CEO. "We announced plans to prepare a marketing application in Europe based on the results of the first fidaxomicin Phase 3 trial for Clostridium difficile infection. We also reported positive top-line results from the second prulifloxacin Phase 3 trial for the treatment of infectious diarrhea."

Recent Corporate Highlights

  • Announced plans to prepare a Marketing Authorization Application (MAA) for submission with the European Medicines Agency (EMEA) for approval of fidaxomicin as an oral treatment for Clostridium difficile infection (CDI) based on the results from the Company's first Phase 3 fidaxomicin trial.
  • Production patent for fidaxomicin issued by the United States Patent and Trademark Office.
  • Announced positive results from the second pivotal Phase 3 trial of prulifloxacin for the treatment of infectious diarrhea. The tri
    '/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
2. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
3. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
4. Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
5. First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals GGTI-2418
6. BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals
7. Idenix Pharmaceuticals Reports First Quarter Financial Results
8. Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting
9. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
10. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
11. Vanda Pharmaceuticals Reports First Quarter 2009 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...re-Asia/--ShanghaiBiolaxyannouncedthe,ChineseState...vestigationalnewdrugapplication(IND)foritsoralinsu...totreatdiabetes.ThisIND,approvalallowsBiolaxytoini...sadisordercharacteristicofhighbloodglucoseandpoor,...severemicro-and,macro-vasculardiseases,lossofvisio...
(Date:11/24/2009)...RONTO,Nov.24/PRNewswire-FirstCall/-HamiltonThorneL...providerofadvancedlasersystemsandinstrumentsforthe...ortedoperationalandfinancialresultsforthethirdquar...evenuewas$1.46millioncomparedwith$1.43millioninQ32....1percentinQ3,2008,-Netlossreducedto$148,000compar...
(Date:11/24/2009)...RNewswire/--HealthRoboticstodayannounced,thatithas...,investors.ThisrecentlyformedToronto-basedcompanyw...dwillmarket,install,andsupport,HealthRobotics,i.v....aryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),an...ssistanceonan"asneeded,basis"toitsstrategicpartner...
(Date:11/23/2009)... In a provocative new study, a University of Utah...ions the major cause of global warming cannot be...r society builds the equivalent of one new nuclear...t there will be any substantial near-term departur...oxide emission rates," says the new paper by Tim G...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...CO, Nov. 12 VIA Pharmaceuticals,(Nasdaq: VIAP ),...t of,compounds for the treatment of cardiovascular...nical advisory board. Joining the clinical advisor...rofessor of Medicine,Harvard Medical School, and S...ton, and Jean-Claude Tardif, M.D., Associate Profe...
...Sought for Breakthrough Pain Associated with Chron...Taking Opioid Medications ...on, Inc. (Nasdaq:,CEPH) today announced it has sub...to the U.S. Food and Drug Administration (FDA) see...l tablet) [C-II] for the management of,breakthroug...
..., N.J. -- The Edwin A. Stevens Society of Stevens ...ean of Stevens School of Systems and Enterprises, ...ward at its annual Gala, to be held at the Park Av...g at 7:00 p.m. Attendance at the black-tie event i...ward is presented to a distinguished individual wh...
Other Biology Technology:VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease 2VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease 3VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease 4Cephalon Submits Supplemental New Drug Application for FENTORA 2Cephalon Submits Supplemental New Drug Application for FENTORA 3Cephalon Submits Supplemental New Drug Application for FENTORA 4Cephalon Submits Supplemental New Drug Application for FENTORA 5Cephalon Submits Supplemental New Drug Application for FENTORA 6Cephalon Submits Supplemental New Drug Application for FENTORA 7Dr. Dinesh Verma to be honored with President's Leadership Award at Edwin A. Stevens Society Gala 2Dr. Dinesh Verma to be honored with President's Leadership Award at Edwin A. Stevens Society Gala 3
(Date:11/25/2009)...duced in the stomach, may be used to boost resista...sease, Yale School of Medicine researchers report ...rnal of Neuroscience . , Parkinson,s disease is ... area of the midbrain known as the substantia nigr...Reduced production of dopamine in late-stage Parki...
(Date:11/25/2009)...25, 2009 Soil is the linchpin of the environment,.... Despite that, many students see soil as "just di...l science educators are challenged with the task o...itical importance of soil in the environment. , ... science teachers at University of Nebraska-Lincol...
(Date:11/24/2009)... it has been prescribed by traditional healers in ... and stomach pain to fever and flu. , Now for the...ave been able to scientifically prove the pain rel...nown as Brazilian mint. , Testing this ancient So...her Graciela Rocha was able to show that when prep...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2Announcing 3A Millennium Place Transitional Downtown Living for Women With Eating Disorders 55578 1Announcing 3A Millennium Place Transitional Downtown Living for Women With Eating Disorders 55578 2More Than Four Out of Five Dentists Surveyed Reveal That Texting During Dental Treatment a Common Problem 55576 1More Than Four Out of Five Dentists Surveyed Reveal That Texting During Dental Treatment a Common Problem 55576 2Flu Expert Helps Clear the Confusion About H1N1 Vs Seasonal Flu Vaccination 55574 1Flu Expert Helps Clear the Confusion About H1N1 Vs Seasonal Flu Vaccination 55574 2
...octoral fellow at the University of Oregon, has sh...y of legumes to recruit soil bacteria needed to pr...rsity of Oregon Many farmers applying pesticides ...o growth problems, scientists report in a new stud...test tube and, now, with real plants, a team of sc...
...y in developing countries are being denied an effe...ng to an editorial in this week’s BMJ. , Professor...ntal organisations in developing countries to ensu... , Of the 35 million people with epilepsy who li...treatment at all. As a result, they experience sei...
...ered new clues to a very cold case: the disappeara...conic of all Ice Age giants, according to a June 7...ublication of Cell Press. , DNA lifted from the bo...aled a “genetic signature” of a range expansion af...hs’ migration, the population apparently leveled o...
Other Biology News:Pesticides choke pathway for nature to produce nitrogen for crops 2Pesticides choke pathway for nature to produce nitrogen for crops 3Ancient DNA traces the woolly mammoth's disappearance 2
Rabbit Anti-NPM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
EZ-96 DNA Methylation-Gold Kit from Zymo Research
Acrylamide PAGE 40% Solution from GE Healthcare, formerly Amersham Biosciences
Kinase Chemiluminescent Assay Kit from Upstate
Biology Products: